A Study of Baricitinib in Participants With Rheumatoid Arthritis
← catalyst calendarSponsored by Eli Lilly and Company (industry) · LLY — their whole pipeline →. With Incyte Corporation.
Phase
Phase 4
Status
Completed
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
1,050actual
Sites
119
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2020-02-14 | actual | When the study began enrolling |
| Primary completion | 2025-05-19 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-05-19 | actual | The whole study's end, after follow-up |
| First posted | 2019-09-12 | actual | When this record first appeared on the registry |
| Results posted | 2026-07-10 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-07-10 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Rheumatoid Arthritis
Interventions
- Drug: Baricitinib — also filed as LY3009104
- Drug: TNF Inhibitor — also filed as Etanercept, Adalimumab
Primary outcome
what the primary-completion date above is the date OFPooled JAJA and JAJD: Time From First Dose of Study Treatment to First Event of Venous Thromboembolism (VTE) [Combined Baricitinib Dose Versus TNF Inhibitor]
measured From the first dose of study treatment up to 30 days after the last dose or the last study visit, whichever occurs first (approximately up to 6.1 years for JAJA and 5.3 years for JAJD participants)
Posted documents
hosted by the registry — we link, never re-serveStudy Protocolposted 2024-03-22 · 1.5 MB · Prot_000.pdf
Statistical Analysis Planposted 2025-07-21 · 1.3 MB · SAP_001.pdf
Permalink · LLY's whole pipeline · Catalyst calendar · Every registered study · What changed